1. Home
  2. RCKT vs PANL Comparison

RCKT vs PANL Comparison

Compare RCKT & PANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • PANL
  • Stock Information
  • Founded
  • RCKT 1999
  • PANL 1996
  • Country
  • RCKT United States
  • PANL United States
  • Employees
  • RCKT N/A
  • PANL N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • PANL Marine Transportation
  • Sector
  • RCKT Health Care
  • PANL Consumer Discretionary
  • Exchange
  • RCKT Nasdaq
  • PANL Nasdaq
  • Market Cap
  • RCKT 328.6M
  • PANL 328.2M
  • IPO Year
  • RCKT N/A
  • PANL N/A
  • Fundamental
  • Price
  • RCKT $3.28
  • PANL $5.33
  • Analyst Decision
  • RCKT Buy
  • PANL Strong Buy
  • Analyst Count
  • RCKT 13
  • PANL 1
  • Target Price
  • RCKT $12.96
  • PANL $9.00
  • AVG Volume (30 Days)
  • RCKT 6.0M
  • PANL 222.3K
  • Earning Date
  • RCKT 08-07-2025
  • PANL 08-07-2025
  • Dividend Yield
  • RCKT N/A
  • PANL 3.75%
  • EPS Growth
  • RCKT N/A
  • PANL N/A
  • EPS
  • RCKT N/A
  • PANL 0.16
  • Revenue
  • RCKT N/A
  • PANL $579,781,169.00
  • Revenue This Year
  • RCKT N/A
  • PANL $13.00
  • Revenue Next Year
  • RCKT $108.43
  • PANL N/A
  • P/E Ratio
  • RCKT N/A
  • PANL $33.08
  • Revenue Growth
  • RCKT N/A
  • PANL 15.10
  • 52 Week Low
  • RCKT $2.19
  • PANL $3.93
  • 52 Week High
  • RCKT $22.01
  • PANL $7.50
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 51.17
  • PANL 59.78
  • Support Level
  • RCKT $2.88
  • PANL $5.21
  • Resistance Level
  • RCKT $3.74
  • PANL $5.48
  • Average True Range (ATR)
  • RCKT 0.27
  • PANL 0.16
  • MACD
  • RCKT 0.02
  • PANL 0.03
  • Stochastic Oscillator
  • RCKT 35.43
  • PANL 75.81

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

About PANL Pangaea Logistics Solutions Ltd.

Pangaea Logistics Solutions Ltd and its subsidiaries provide seaborne drybulk logistics and transportation services. It transports various drybulk cargoes including grains, coal, iron, ore, pig, iron, hot briquetted iron, bauxite, alumina, cement clinker, dolomite, and limestone. The company provides ocean transportation services to clients utilizing an ocean-going fleet of motor vessels in the Handymax, Supramax, Ultramax, Panamax, and Post-Panamax segments. Its services include cargo loading, cargo discharge, vessel chartering, voyage planning, and technical vessel management. The company derives all of its revenues from contracts of affreightment, voyage charters and time charters. Geographically, it derives key revenue from the United States, followed by Canada, Germany, and others.

Share on Social Networks: